CD8A and cancer: Among the many F9 associated genes overexpressed in SMC vs. TCGA were CD8A, a marker of the cytotoxic T lymphocytes and PD-L1, an important mediator of immune checkpoint and target of multiple cancer immunotherapies (Fig. 5b).